pancan.ai/Ask
what is known about trial:nct:NCT06690281
Understood asRecord NCT06690281View getStudy → table
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies NCT06690281↗ Outcome: Stopped early
Computed from the knowledge API (getStudy); every record links to its source.